Clinical and Experimental Pediatrics

The Korean Pediatric Society (대한소아청소년과학회)
권호 표지
DOI QR코드

DOI QR Code

Novel influenza A (H1N1) 2009 infection in the pediatric patients with hematologic and oncologic diseases in the Yeungnam region in Korea

  • Kang, Seok-Jeong (Department of Pediatrics, College of Medicine, Yeungnam University) ;
  • Lee, Jae-Min (Department of Pediatrics, College of Medicine, Yeungnam University) ;
  • Hah, Jeong-Ok (Department of Pediatrics, College of Medicine, Yeungnam University) ;
  • Shim, Ye-Jee (Department of Pediatrics, College of Medicine, Kyungbook National University) ;
  • Lee, Kun-Soo (Department of Pediatrics, College of Medicine, Kyungbook National University) ;
  • Shin, Hyun-Jung (Department of Pediatrics, College of Medicine, Keimyung University) ;
  • Kim, Heung-Sik (Department of Pediatrics, College of Medicine, Keimyung University) ;
  • Choi, Eun-Jin (Department of Pediatrics, College of Medicine, Daegu Catholic University) ;
  • Jeon, So-Eun (Department of Pediatrics, College of Medicine, Pusan National University) ;
  • Lim, Young-Tak (Department of Pediatrics, College of Medicine, Pusan National University) ;
  • Park, Ji-Kyeong (Department of Pediatrics, College of Medicine, Inje University) ;
  • Park, Eun-Sil (Department of Pediatrics, College of Medicine, Gyeongsang National University)
  • Received : 2010.09.15
  • Accepted : 2010.12.21
  • Published : 2011.03.15
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: Natural history and consequences of the novel 2009 influenza A H1N1(2009 H1N1) infection in immunocompromised pediatric patients are not yet fully understood. In this study, we investigated the clinical features and outcomes of the 2009 H1N1 infection in pediatric patients with hematological and oncological diseases. Methods: We retrospectively reviewed the medical records of 528 patients who had hematological and oncological diseases and who were treated at 7 referral centers located in the Yeungnam region. Among the 528 patients, 27 with definite diagnosis of 2009 H1N1 infection were the subjects of this study. All patients were divided into the following 3 groups: patients who were receiving chemotherapy (group 1), patients who were immunosuppressed due to a nonmalignant hematological disease (group 2), and patients who were off chemotherapy and had undergone their last chemotherapy course within 2 years from the influenza A pandemic (group 3). Results: All 28 episodes of 2009 H1N1 infection were treated with the antiviral agent oseltamivir ($Tamiflu^{(R)}$), and 20 episodes were treated after hospitalization. Group 1 patients had higher frequencies of lower respiratory tract infection and longer durations of fever and hospitalization as compared to those in group 2. Ultimately, all episodes resolved completely with no complications. Conclusion: These results suggest that early antiviral therapy did not influence the morbidity or mortality of pediatric patients with hematological and oncological diseases in the Yeungnam region of Korea after the 2009 H1N1 infection. However, no definite conclusions can be drawn because of the small sample size.

Keywords

References

  1. World Health Organization [homepage on the Internet]. Geneva, Switzerland: WHO c2009 [updated 2009 June 11 cited 2009 July 17]. Global alert and response; [about 2 screens]. Available from: URI: http://www.cdc.gov/h1n1flu/updates/060509.htm
  2. Khanna N, Steffen I, Studt JD, Schreiber A, Lehmann T, Weisser M, et al. Outcome of influenza infections in outpatients after allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis 2009;11:100-5. https://doi.org/10.1111/j.1399-3062.2008.00362.x
  3. Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team, Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009;360:2605-15. https://doi.org/10.1056/NEJMoa0903810
  4. O'Riordan S, Barton M, Yau Y, Read SE, Allen U, Tran D. Risk factors and outcomes among children admitted to hospital with pandemic H1N1 influenza. CMAJ 2010;182:39-44. https://doi.org/10.1503/cmaj.091724
  5. Shin SY, Kim JH, Kim HS, Kang YA, Lee HG, Kim JS, et al. Clinical characteristics of Korean pediatric patients critically ill with influenza A (H1N1) virus. Pediatr Pulmonol 2010;45:1014-20. https://doi.org/10.1002/ppul.21288
  6. Korea Centers for Disease Control and Prevention (KCDC). Epidemiologic characteristics of influenza A (H1N1) 2009 confirmed cases in Korea. Available from: URI: http://cdc.go.kr/kcdchome/jsp/observation/ common/brd/COMMBRD0200Detail.jsp?boardid=1249&boardseq=570&menuid=110545&appid=null&contentid=null&pageNum=1&sub=4
  7. Louie JK, Acosta M, Winter K, Jean C, Gavali S, Schechter R, et al. Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in california. JAMA 2009;302:1896-902. https://doi.org/10.1001/jama.2009.1583
  8. Thirumala R, Ramaswamy M, Chawla S. Diagnosis and management of infectious complications in critically ill patients with cancer. Crit Care Clin 2010;26:59-91. https://doi.org/10.1016/j.ccc.2009.09.007
  9. Lalayanni C, Sirigou A, Iskas M, Smias C, Sakellari I, Anagnostopoulos A. Outbreak of novel influenza A (H1N1) in an adult haematology department and haematopoietic cell transplantation unit: clinical presentation and outcome. J Infect 2010;61:270-2. https://doi.org/10.1016/j.jinf.2010.06.013
  10. George B, Ferguson P, Kerridge I, Gilroy N, Gottlieb D, Hertzberg M. The clinical impact of infection with swine flu (H1N109) strain of influenza virus in hematopoietic stem cell transplant recipients. Biol Blood Marrow Transplant 2011;17:147-53. https://doi.org/10.1016/j.bbmt.2010.07.004
  11. Hajjar LA, Mauad T, Galas FR, Kumar A, da Silva LF, Dolhnikoff M, et al. Severe novel influenza A (H1N1) infection in cancer patients. Ann Oncol 2010;21:2333-41. https://doi.org/10.1093/annonc/mdq254
  12. Redelman-Sidi G, Sepkowitz KA, Huang CK, Park S, Stiles J, Eagan J, et al. 2009 H1N1 influenza infection in cancer patients and hematopoietic stem cell transplant recipients. J Infect 2010;60:257-63. https://doi.org/10.1016/j.jinf.2010.01.009
  13. Launes C, Rives S, Catala A, Berrueco R, Toll T, Camos M, et al. Pandemic influenza A (2009 H1N1) in children with acute lymphoblastic leukaemia. Br J Haematol 2010;149:874-8. https://doi.org/10.1111/j.1365-2141.2010.08178.x
  14. Caselli D, Carraro F, Castagnola E, Ziino O, Frenos S, Milano GM, et al. Morbidity of pandemic H1N1 influenza in children with cancer. Pediatr Blood Cancer 2010;55:226-8. https://doi.org/10.1002/pbc.22619
  15. Chemaly RF, Ghosh S, Bodey GP, Rohatgi N, Safdar A, Keating MJ, et al. Respiratory viral infections in adults with hematologic malignancies and human stem cell transplantation recipients: a retrospective study at a major cancer center. Medicine (Baltimore) 2006;85:278-87. https://doi.org/10.1097/01.md.0000232560.22098.4e
  16. Mendoza Sanchez MC, Ruiz-Contreras J, Vivanco JL, Fernandez-Carrion F, Baro Fernandez M, Ramos JT, et al. Respiratory virus infections in children with cancer or HIV infection. J Pediatr Hematol Oncol 2006;28:154-9. https://doi.org/10.1097/01.mph.0000210061.96075.8e
  17. Tasian SK, Park JR, Martin ET, Englund JA. Influenza-associated morbidity in children with cancer. Pediatr Blood Cancer 2008;50:983-7. https://doi.org/10.1002/pbc.21472
  18. Gooskens J, Jonges M, Claas EC, Meijer A, Kroes AC. Prolonged influenza virus infection during lymphocytopenia and frequent detection of drug-resistant viruses. J Infect Dis 2009;199:1435-41. https://doi.org/10.1086/598684

Cited by

  1. 2009 Pandemic Influenza A(H1N1) Infections in the Pediatric Cancer Patients and Comparative Analysis with Seasonal Influenza vol.19, pp.2, 2011, https://doi.org/10.14776/kjpid.2012.19.2.61